Acknowledging National Cancer Research Month – May 2021

May is National Cancer Research month, initiated and supported by the American Association for Cancer Research. New advances and developments within cancer research are helping patients live longer – but there is still more work to be done.

May 21, 2021
View the Post

International Clinical Trials Day 2021

On May 20th, PharPoint celebrates International Clinical Trials Day 2021.

May 20, 2021
View the Post

The History of Clinical Research | Clinical Trials Day 2021

Every year on May 20th, the industry celebrates International Clinical Trials Day, acknowledging patients and their families, nurses and physicians, researchers, and the many others who participate in clinical research to make advances in treatments possible.

May 15, 2021
View the Post

PharPoint to Attend World Vaccine Congress Washington 2021

Meet with PharPoint’s team at the World Vaccine Congress Washington 2021. The free event, held virtually, is being held May 4th to May 6th.

April 22, 2021
View the Post

PharPoint sponsors Upcoming Spring 2021 Oncology Investor Conference

PharPoint Research is thrilled to be a CRO Sponsor for the Spring 2021 Oncology Investor Conference. This event is the preeminent investment event in oncology – for investors seeking to invest in private and public cancer companies, and for cancer related companies seeking investment. 

March 4, 2021
View the Post

Acknowledging Rare Disease Day 2021

In honor of Rare Disease Day 2021, PharPoint Research is diving into the facts, figures, and challenges surrounding rare diseases and rare disease clinical research.

February 22, 2021
View the Post

Acknowledging World Cancer Day 2021

February 4th marks World Cancer Day, led by the Union for International Cancer Control (UICC). As a CRO with expertise in oncology, PharPoint Research is dedicated to uniting in the fight against cancer.

February 4, 2021
View the Post

Acknowledging Rare Disease Day 2020

This February 29th, PharPoint acknowledges Rare Disease Day. We are relentless in supporting clients so that they may advance rare disease research and the approval of breakthrough treatments.

February 27, 2020
View the Post